Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 29/3/2020
SIETES contiene 92954 citas

 
 
 1 a 7 de 7 
Presentar resultados
Seleccionar todas
1. Cita con resumen
Jenkins DJA, Kendall CWC, Vuksan V, Faulkner D, Augustin LSA, Mitchell S, Ireland C, Srichaikul K, Mirrahimi A, Chiavaroli L, Mejia SB, Nishi S, Sahye-Pudaruth S, Patel D, Bashyam B, Vidgen E, de Souza RJ, Sievenpiper JL, Coveney J, Josse RG, Leiter LA. Effect of lowering the glycemic load with canola oil on glycemic control and cardiovascular risk factors: a randomized controlled trial. Diabetes Care 2014;37:1806-14. [Ref.ID 97658]
2. Cita con resumen
Jenkins DJA, Jones PJH, Lamarche B, Kendall CWC, Faulkner D, Cermakova L, Gigleux I, Ramprasath V, de Souza R, Ireland C, Patel D, Srichaikul K, Abdulnoour S, Bashyam B, Collier C, Hoshizaki S, Josse RG, Leiter LA, Connelly PW. Effect of a dietary portfolio of cholesterol-lowering foods given at 2 levels of Intensity of dietary advice on serum lipids in hyperlipidemia . JAMA 2011;306:831-9. [Ref.ID 91008]
3.
Sawka AM, Ray JG, Yi Q, Josse RG, Lonn E. Randomized clinical trial of homocysteine level-lowering therapy and fractures. Arch Intern Med 2007;167:2136-8. [Ref.ID 81528]
4.Tiene citas relacionadas
Jenkins DJA, Kendall CWC, Marchie A, Faulkner D, Wong JMW, de Souza R, Emam A, Parker T L, Vidgen E, Lapsley KG, Trautwein EA, Josse RG, Leiter LA, Connelly PW. Effects of a dietary portfolio of cholesterol-lowering food vs lovastatin on serum lipids and C-reactive protein. JAMA 2003;290:502-10. [Ref.ID 66991]
5. Cita con resumen
Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karsik A, Laakso M, for the STOP-NIDDM Trial Research Group. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance. The STOP-NIDDM Trial. JAMA 2003;290:486-94. [Ref.ID 66989]
6. Cita con resumen
Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M, for the STOP-NIDDM Trial Research Group. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 2002;359:2072-7. [Ref.ID 62647]
7. Cita con resumen
Chiasson JL, Josse RG, Hunt JA, Palmason C, Rodger N W, Ross S A, Ryan E A, Tan MH, Wolever TMS. The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial. Ann Intern Med 1994;121:928-35. [Ref.ID 23295]
Seleccionar todas
 
 1 a 7 de 7